Table 3.
C (N = 5) |
PD (N = 9) |
MSA (N = 6) |
||||||
---|---|---|---|---|---|---|---|---|
T1 | T2 | T1 | T2 | T1 | T2 | |||
Prosaccade | Error rate (%) | Mean (±SE) [Median] | 0.4 (±0.4) [0.0] | 1.7 (±0.8) [2.1] | 1.4 (±0.8) [0.0] | 1.5 (±0.8) [0.0] | 1.5 (±0.7) [1.0] | 2.7 (±2.7)a [0.0] |
Changes within groups, test statistics [p] | Z = 1.18 [p = 0.24] | Z = −0.00 [p = 1.00] | Z = 1.22 [p = 0.22] | |||||
Changes among groups, test statistics [p] | χ2(2) = 1.09 [p = 0.58] | |||||||
Latency (ms) | Mean (±SE) [Min, Max] | 241 (±12) [219, 287] | 235 (±6) [202, 254] | 247 ± 10 [207, 305] | 254 (±9) [227, 297] | 332 (±34)a [230, 403] | 308 (±24)a [225, 358] | |
Changes within groups, test statistics [p] | t(31) = −0.64 [p = 0.53] | t(31) = 0.88 [p = 0.39] | t(31) = −2.30 [p = 0.028] | |||||
Changes among groups, test statistics [p] | F(2, 31) = 2.83 [p = 0.074] | |||||||
Antisaccade | Error rate (%) | Mean (±SE) [Median] | 16.2 (±2.0) [16.7] | 12.5 (±2.5) [11.9] | 37.6 (±7.8) [38.3] | 34.8 (±8.8) [21.3] | 37.8 (±10.8) [26.4] | 45.7 (±12.8) [39.7] |
Changes within groups, test statistics [p] | Z = −0.97 [p = 0.33] | Z = −0.77 [p = 0.44] | Z = 1.35 [p = 0.18] | |||||
Changes among groups, test statistics [p] | χ2(2) = 2.55 [p = 0.28] | |||||||
Latency (ms) | Mean (±SE) [Min, Max] | 409 (±37) [312, 504] | 378 (±38) [281, 505] | 430 (±31) [284, 586] | 407 (±27) [295, 539] | 445 (±38) [315, 567] | 440 (±33) [341, 555] | |
Changes within groups, test statistics [p] | t(33) = −2.11 [p = 0.043] | t(33) = −2.24 [p = 0.032] | t(33) = −0.13 [p = 0.90] | |||||
Changes among groups, test statistics [p] | F(2, 33) = 1.06 [p = 0.36] |
C, controls; PD, Parkinson’s disease; MSA, multiple system atrophy.
p Values (p) for age adjusted group effects using generalized linear model with Poisson link for error rate and one way analysis of variance for latency.
aOne data point missing.